There was no difference in overall survival between groups ( median 76 months [ 95 % CI 61-91 ] vs 68 months [ 95 % CI 51-85 ] in the metformin group ; hazard ratio [ HR ] 1056 [ 95 % CI 072-155 ] ; log-rank p = 078 ) .